This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2023 — Pharmaceutical Compliance Congress


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
April 25 - 27, 2023The Ritz-Carlton, Tysons Corner | McLean, VA

Kelli McGillicuddy
Standards & Governance Global Lead for Biosimilars Business Unit (BBU) at Biogen


Kelli McGillicuddy is the Standards & Governance Global Lead for Biogen’s Biosimilars Business. With over 12+ years of professional experience in life sciences, she previously worked at Genzyme Corporation before joining Biogen in 2013. During the past few years, Kelli launched the Standards & Governance role for Biogen’s International Partner Markets in Switzerland and Biogen’s Australia & New Zealand affiliate. In both roles, Kelli served as a strategic partner to the business providing support, process improvement creation and initiatives, and promoted an ethical, compliant, and accountable culture. Kelli has extensive business and cross-cultural experience in US, EU, Middle East, North Africa, LATAM and APAC regions where she empowers senior business leaders and teammates. Most recently, Kelli supported the launch of Biogen’s new Biosimilars business in the US.

Agenda Sessions

  • Infusing Innovation into Compliance